Survival of Multiple Myeloma in the Lebanese Population between January 2005 and December 2017

Massoud, Marcel; Tarabay, Anthony; Zeghondy, Jean; Rached, Layal; Kerbage, Fouad; Nasr, Fadi; Chahine, Georges

doi:10.1016/j.clml.2018.07.138

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For instance, Lebanon faces the lack of epidemiological, etiological, and clinical studies in the context of MM. While scant, published data reveal the increasing trend in MM incidence [ 7 ], the poor survival of elderly patients, and the need for less toxic alternative treatment options [ 8 , 9 ]. With this perspective, areas of current practice that are the focus of considerable debate and constitute a challenge/gap in the management of MM in the Middle East are explored, with a special focus on the Lebanese situation.…”

Section: Introductionmentioning

confidence: 99%

Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective

et al. 2022

View full text Add to dashboard Cite

Multiple myeloma (MM) is a prevalent hematological malignancy. Resource-constrained settings such as the Middle East are particularly burdened by the increasing trends in MM morbidity and mortality in addition to challenges in the management of MM. It thus becomes necessary to identify and address debatable areas of current practice and gaps in the management of MM in the Middle East. With a special focus on the Lebanese situation, the first-line treatment of the very elderly (> 80 years old) is discussed, in addition to the impact of relapse type (biochemical or clinical relapse) on maintenance therapy, the choice of first relapse therapy in relation to maintenance therapy, and the role of MRD in the MM treatment landscape. The need for realistic management guidelines accounting for local resources and expertise, in addition to the reflection of drug accessibility and cost on clinical practice are recognized.

show abstract

Section: Introductionmentioning

confidence: 99%